Related Experiment Video
Updated: Mar 7, 2026

02:28
Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients
Published on: March 1, 2024
973
Psoriasis in Children.
Indian Journal of Dermatology, Venereology and Leprology
|February 23, 2017
Summary
Childhood psoriasis affects 0.1% of dermatology outpatients, with onset typically between 4-8 years. Guttate lesions, often linked to throat infections, responded well to penicillin.
Area of Science:
- Dermatology
- Pediatrics
- Epidemiology
Background:
- Psoriasis is a chronic inflammatory skin condition.
- Childhood-onset psoriasis requires specific epidemiological understanding.
- Prevalence and characteristics in Indian pediatric populations are less understood.
Purpose of the Study:
- To determine the prevalence of childhood psoriasis in Indian outpatients.
- To describe the clinical characteristics, age of onset, and family history.
- To evaluate treatment responses in pediatric psoriasis patients.
Main Methods:
- Prospective study design.
- Inclusion of general skin disease outpatients.
- Data collection on demographics, clinical presentation, family history, and treatment outcomes.
Main Results:
- Overall prevalence of childhood psoriasis was 0.1% among outpatients.
- 8.5% of Indian psoriatics had childhood onset, peaking between 4-8 years.
- Plaque psoriasis was most common; guttate lesions (25%) often followed throat infections and were itchy.
- Nail involvement exceeded 60%; facial and scalp involvement patterns differed from adults.
- Coal tar treatment showed satisfactory response; penicillin was effective for guttate lesions.
- Pustular, erythrodermic, and psoriatic arthritis were rare in this cohort.
Conclusions:
- Childhood psoriasis has a distinct epidemiological profile in India.
- Early onset, common types, and specific triggers like throat infections are key features.
- Effective treatment options include coal tar and penicillin for specific lesion types.
Related Concept Videos
Skin Diseases and Disorders
5.9K
Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
5.9K
Skin Cancer
6.4K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
6.4K
Pharmacokinetics in Pediatric Patients: Drug Excretion
342
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
342
Pharmacokinetics in Pediatric Patients: Drug Metabolism
304
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
304
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
575
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
575
Pharmacokinetics in Pediatric Patients: Drug Distribution
405
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
405

